By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rubicon Genomics has signed an agreement to provide Kreatech Diagnostics with its OmniPlex-D whole-genome amplification technology.

Under the agreement, Rubicon will provide Kreatech with reagents incorporating elements of the OmniPlex technology, which Kreatech will use in the manufacture of its Poseidon fluorescence in situ hybridization probes. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.